Prostatis Group’s Amplify CWP Enhanced Dividend Income ETF DIVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$21M Buy
468,993
+10,765
+2% +$493K 5.38% 2
2025
Q4
$20.4M Sell
458,228
-389
-0.1% -$17.5K 4.87% 2
2025
Q3
$20.4M Buy
458,617
+16,655
+4% +$722K 5.12% 2
2025
Q2
$18.8M Buy
441,962
+47,002
+12% +$1.91M 5.38% 2
2025
Q1
$16.1M Buy
394,960
+61,767
+19% +$2.56M 5.08% 4
2024
Q4
$13.5M Buy
333,193
+18,773
+6% +$779K 3.93% 5
2024
Q3
$13M Buy
314,420
+18,972
+6% +$754K 4.24% 3
2024
Q2
$11.4M Buy
295,448
+29,683
+11% +$1.14M 4.01% 4
2024
Q1
$10.3M Buy
265,765
+28,916
+12% +$1.08M 3.91% 4
2023
Q4
$8.66M Sell
236,849
-59,221
-20% -$2.08M 3.62% 5
2023
Q3
$10.3M Sell
296,070
-10,220,900
-97% -$368M 5.06% 4
2023
Q2
$11M Buy
10,516,970
+10,217,656
+3,414% +$363M 5.12% 4
2023
Q1
$10.6M Sell
299,314
-7,939
-3% -$282K 5.6% 1
2022
Q4
$11M Buy
307,253
+9,991
+3% +$352K 6.72% 2
2022
Q3
$9.52M Buy
297,262
+49,430
+20% +$1.71M 10.97% 1
2022
Q2
$8.31M Buy
247,832
+171,287
+224% +$6.1M 12.96% 2
2022
Q1
$2.87M Buy
76,545
+28,869
+61% +$1.07M 2.3% 17
2021
Q4
$1.82M Buy
47,676
+19,907
+72% +$737K 1.12% 29
2021
Q3
$970K Buy
27,769
+17,726
+177% +$643K 0.58% 40
2021
Q2
$360K Sell
10,043
-1,346
-12% -$47.9K 0.25% 73
2021
Q1
$392K Buy
+11,389
New +$381K 0.31% 71

Other funds holding DIVO

Prostatis Group's DIVO Position: Q1 2026 in Review

Prostatis Group increased its Amplify CWP Enhanced Dividend Income ETF (DIVO) stake by 2.3% in Q1 2026, buying an estimated $493K and bringing the position to 468,993 shares worth $21M. The position accounts for 5.38% of the portfolio, ranked #2.

Prostatis Group first reported a position in DIVO in Q1 2021 and has held it in 21 quarters since. 383 funds tracked by Wall St. Rank hold DIVO as of Q1 2026.

  • Prostatis Group held 468,993 shares of Amplify CWP Enhanced Dividend Income ETF worth $21M as of Q1 2026.
  • Prostatis Group bought 10,765 Amplify CWP Enhanced Dividend Income ETF shares in Q1 2026, an estimated $493K.
  • Amplify CWP Enhanced Dividend Income ETF made up 5.38% of Prostatis Group's portfolio in Q1 2026, its #2 holding.
  • Prostatis Group first reported a position in Amplify CWP Enhanced Dividend Income ETF in Q1 2021 and has held it in 21 quarters since.
  • 383 funds tracked by Wall St. Rank held Amplify CWP Enhanced Dividend Income ETF as of Q1 2026.

Based on Prostatis Group's 13F filing for Q1 2026, filed 12 May 2026.